Intas Pharmaceuticals Limited — Tinidazole Exporter Profile
Indian Pharmaceutical Exporter · #7 for Tinidazole · $425.8K export value · DGFT Verified
Intas Pharmaceuticals Limited is the #7 Indian exporter of Tinidazole with $425.8K in export value and 18 verified shipments. Intas Pharmaceuticals Limited holds a 2.3% market share in Tinidazole exports across 3 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.
Intas Pharmaceuticals Limited — Tinidazole Export Profile: Buyers & Destinations
Where Does Intas Pharmaceuticals Limited Export Tinidazole?
Intas Pharmaceuticals Limited exports Tinidazole to 3 countries. The largest destination is TANZANIA accounting for 61.8% of Intas Pharmaceuticals Limited's Tinidazole shipments, followed by UGANDA (25.4%) and ZIMBABWE (12.8%). These destinations reflect Intas Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Tinidazole from Intas Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER., | TANZANIA | $286.7K | 9 |
| TO THE ORDER OF- | UGANDA | $68.7K | 5 |
| TO THE OREDR.. | TANZANIA | $31.1K | 1 |
| TO THE ORDER | UGANDA | $22.8K | 1 |
| TO THE ORDER OF | UGANDA | $16.6K | 2 |
Intas Pharmaceuticals Limited supplies Tinidazole to 5 buyers globally. The largest buyer is TO THE ORDER., (TANZANIA), followed by TO THE ORDER OF- (UGANDA) and TO THE OREDR.. (TANZANIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Tinidazole Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?
India exported $8.5M worth of Tinidazole through 2,271 shipments from 315 suppliers to 105 countries, serving 535 buyers globally. Intas Pharmaceuticals Limited contributes $425.8K to this total, accounting for 2.3% of India's Tinidazole exports. Intas Pharmaceuticals Limited ships Tinidazole to 3 countries through 5 buyers.
What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Tinidazole Exports?
Intas Pharmaceuticals Limited's average Tinidazole shipment value is $23.7K per consignment, based on 18 shipments totaling $425.8K. The largest destination is TANZANIA (61.8% of Intas Pharmaceuticals Limited's Tinidazole exports).
How Does Intas Pharmaceuticals Limited Compare to Other Indian Tinidazole Exporters?
Intas Pharmaceuticals Limited ranks #7 among 315 Indian Tinidazole exporters with a 2.3% market share. The top 3 exporters are MICRO LABS LIMITED ($1.5M), CIPLA LIMITED ($1.4M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($1.1M). Intas Pharmaceuticals Limited processed 18 shipments to 3 destination countries.
What Tinidazole Formulations Does Intas Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMA DRUGS AND MEDICINE-HELIGO 500 7X6T KIT(TAN-DDN Each kit contains:A.2 Tinidazole QTY.6730X7X6TAB(282660)AS PER INV | $49.3K | 1 |
| PHARMA DRUGS AND MEDICINE-HELIGO 500 7X6T KIT(TAN-DDN Each kit contains:A2 Tinidazole Tab 500 mg Each QTY.6696X7X6TAB | $48.9K | 1 |
| PHARMACEUTICAL DRUGS AND MEDICINE-HELIGO500 7X6 T KIT(ENGGEN-DDN Each kit contains:A. 2 Tinidazole Tab- QTY.4687X7X6TAB | $37.7K | 1 |
| PHARMA DRUGS AND MEDICINE-HELIGO 500 7X6T KIT(TAN-DDN Each kit contains:A.2 Tinidazole Tablets 500 mg QTY.4109X7X6TAB | $31.8K | 1 |
| PHARMA DRUGS AND MEDICINES-HELIGO 500 7X6 T KIT(TAN-DDN Each kit contains:A. 2Tinidazole Tab- QTY.4715X7X6TAB-AS PER INV | $31.1K | 1 |
| PHARMA DRUGS AND MEDICINE-HELIGO 500 7X6T KIT(TAN-DDN Each kit contains:A.2 Tinidazole QTY.3825X7X6TAB FOC AS PER INV | $29.8K | 1 |
| PHARMA DRUGS AND MEDICINE-HELIGO 500 7X6T KIT(TAN-DDN Each kit contains:A.2Tinidazole Tabl 500mg Each QTY.3643X7X6TAB | $28.3K | 1 |
| PHARMA DRUGS AND MEDICINE-HELIGO 500 7 KIT ZIMBABWE(E2) Each kit contains:A. 2 Tinidazole Tablets 500 mg QTY.3390X7X6TAB | $27.5K | 1 |
| PHARMA DRUGS AND MEDICINE-HELIGO 500 7 KIT ZIMBABWE(E2) Each kit contains:A.2 Tinidazole Tablets 500 mg QTY.3169X7X6TAB | $26.9K | 1 |
| PHARM DRUG&MED HELIGO 500 7X6 T KIT(ENGGEN-DDN)EACH KIT CONT:A. 2 TINIDAZOLE TABLETS 500 MG EACH FILM COATED (ASPERINV) | $22.8K | 1 |
Intas Pharmaceuticals Limited exports 18 distinct Tinidazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS AND MEDICINE-HELIGO 500 7X6T KIT(TAN-DDN Each k with 1 shipments worth $49.3K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Intas Pharmaceuticals Limited Compare to Nearest Tinidazole Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | CAPLIN POINT LABORATORIES LIMITED | $788.3K | 31 | 6 | $25.4K |
| 6 | ZYDUS LIFESCIENCES LIMITED | $522.8K | 26 | 9 | $20.1K |
| 7 | INTAS PHARMACEUTICALS LIMITED ★ | $425.8K | 18 | 3 | $23.7K |
| 8 | LINCOLN PHARMACEUTICALS LTD | $383.3K | 18 | 5 | $21.3K |
| 9 | MEDICO REMEDIES LIMITED | $379.6K | 13 | 6 | $29.2K |
Intas Pharmaceuticals Limited ranks #7 among 315 Indian Tinidazole exporters. Average shipment value of $23.7K compared to the market average of $27.1K. The closest competitors by value are CAPLIN POINT LABORATORIES LIMITED and ZYDUS LIFESCIENCES LIMITED.
Which Indian Ports Ship Tinidazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 300 | 13.2% |
| DELHI AIR | 261 | 11.5% |
| SAHAR AIR | 228 | 10.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 201 | 8.9% |
| NHAVA SHEVA SEA (INNSA1) | 160 | 7.0% |
| JNPT | 112 | 4.9% |
| JNPT/ NHAVA SHEVA SEA | 89 | 3.9% |
| Delhi Air | 71 | 3.1% |
Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Tinidazole Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)
Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.
Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.
About Intas Pharmaceuticals Limited
Intas Pharmaceuticals Limited exports 75 products worth $372.3M. Beyond Tinidazole, top products include Ras, Mycophenolate, Tacrolimus, Apixaban, Ezetimibe. View the complete Intas Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tinidazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tinidazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 18 individual customs records matching Intas Pharmaceuticals Limited exporting Tinidazole, covering 18 formulations to 3 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 105+ countries, 535+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tinidazole Export Data from Intas Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Intas Pharmaceuticals Limited's Tinidazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Intas Pharmaceuticals Limited
Full Company Profile →
75 products · $372.3M total trade · 19 categories
Tinidazole Stats
Company Overview
Top Products by Intas Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Intas Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tinidazole. For current shipment-level data, contact TransData Nexus.